{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:28:02Z","timestamp":1761182882868,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jiac.2014.04.006","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T11:46:09Z","timestamp":1400586369000},"page":"465-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: Incidence and associated factor"],"prefix":"10.1016","volume":"20","author":[{"given":"Kuan-Yin","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Jui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Song","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szu-Min","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sui-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hsing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2013","series-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","key":"10.1016\/j.jiac.2014.04.006_bib1"},{"key":"10.1016\/j.jiac.2014.04.006_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e328013d9d7","article-title":"Efficacy and safety of TMC114\/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1","volume":"21","author":"Katlama","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2014.04.006_bib3","doi-asserted-by":"crossref","first-page":"F11","DOI":"10.1097\/QAD.0b013e3280b07b47","article-title":"Week 24 efficacy and safety of TMC114\/ritonavir in treatment-experienced HIV patients","volume":"21","author":"Haubrich","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2014.04.006_bib4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/QAI.0b013e3181359cfb","article-title":"Safety and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced patients: 24-week results of POWER 3","volume":"46","author":"Molina","year":"2007","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2014.04.006_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(07)61049-6","article-title":"Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial","volume":"370","author":"Madruga","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2014.04.006_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1468-1293.2012.01060.x","article-title":"Final 192-week efficacy and safety of once-daily darunavir\/ritonavir compared with lopinavir\/ritonavir in HIV-1-infected treatment-naive patients in the ARTEMIS trial","volume":"14","author":"Orkin","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/j.jiac.2014.04.006_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e328345ee95","article-title":"Week 48 analysis of once-daily vs. twice-daily darunavir\/ritonavir in treatment-experienced HIV-1-infected patients","volume":"25","author":"Cahn","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2014.04.006_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.biopha.2012.12.005","article-title":"Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)","volume":"67","author":"Menzaghi","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jiac.2014.04.006_bib9","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/00365548.2012.751507","article-title":"Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients","volume":"45","author":"Zucman","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jiac.2014.04.006_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jmv.23404","article-title":"Switching to darunavir\/ritonavir 800\/100\u00a0mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1","volume":"85","author":"Ghosn","year":"2013","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2014.04.006_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jiac.2014.01.004","article-title":"Skin rash induced by ritonavir-boosted darunavir is common, but generally tolerable in an observational setting","volume":"20","author":"Nishijima","year":"2014","journal-title":"J Infect Chemother"},{"year":"2013","series-title":"Guidelines for diagnosis and treatment of HIV\/AIDS","author":"Centers for Disease Control, R.O.C. (Taiwan)","key":"10.1016\/j.jiac.2014.04.006_bib12"},{"year":"2009","series-title":"Division of AIDS table for grading the severity of adult and pediatric adverse events","author":"National Institute of Allergy and Infectious Diseases","key":"10.1016\/j.jiac.2014.04.006_bib13"},{"key":"10.1016\/j.jiac.2014.04.006_bib14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jac\/dkr601","article-title":"Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan","volume":"67","author":"Lai","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.04.006_bib15","unstructured":"Stanford University HIV Drug Resistance Database. Available at: http:\/\/hivdb.stanford.edu. [accessed 01.04.14]."},{"key":"10.1016\/j.jiac.2014.04.006_bib16","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"Johnson","year":"2013","journal-title":"Top Antivir Med"},{"key":"10.1016\/j.jiac.2014.04.006_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jac\/dkn292","article-title":"Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection","volume":"62","author":"Borras-Blasco","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.04.006_bib18","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jaci.2010.11.048","article-title":"Immune pathomechanism of drug hypersensitivity reactions","volume":"127","author":"Pichler","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jiac.2014.04.006_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jac\/dkm243","article-title":"Incidence of abacavir hypersensitivity and its relationship with HLA-B*5701 in HIV-infected patients in Taiwan","volume":"60","author":"Sun","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2014.04.006_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAD.0b013e3282f37812","article-title":"HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz","volume":"22","author":"Vitezica","year":"2008","journal-title":"AIDS"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1400172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X1400172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:51:52Z","timestamp":1761159112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X1400172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1341321X1400172X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2014.04.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin rash related to once-daily boosted darunavir-containing antiretroviral therapy in HIV-infected Taiwanese: Incidence and associated factor","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2014.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}